Oct 17 U.S. FDA -
* U.S. FDA - Awards 21 grants to stimulate product development for rare diseases
* U.S. FDA - New clinical trial research grants total more than $23 million over next four years
* U.S. FDA - Awards the grants through the Orphan Products Clinical Trials Grants Program Source text (bit.ly/2dvqhUQ)
Aixtron, Fujian to explore what is left of deal after U.S. veto
FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.